Cannabis researcher and cultivator Avicanna announced a joint venture Thursday with the Canadian full-service testing and research laboratory Sigma Analytical Services Inc. to set up the first cannabis-exclusive analytical facility in South America that Canadian, European, U.S. and EU GMP standards.
The laboratory will perform testing on cannabis products analyze the presence of pesticides, heavy metals, residual solvents, aflatoxins and microbials, as well as perform genotyping and cannabinoid and terpene profiling.
“This level of world-class quality testing is a necessity for Avicanna’s pharmaceutical development and clinical development programs, but will also be established as a minimum requirement for all of our product categories as we aim to establish a global standard for cannabinoid-based solutions,” Avicanna CEO Aras Azadian said in a statement.
Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider…